Scholar Rock Holding
Cambridge, Massachusetts, United States
101-250 Employees
Senior Manager /Associate Director, Biostatistics
Cambridge, MA, US
Posted on Sep 22, 2026
Job Description
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Scholar Rock is seeking a motivated, energetic, and outstanding individual with experience in clinical statistics to join our team. The Senior Manager/Associate Director, Biostatistics will participate in all biostatistics activities in a clinical development program from clinical design to regulatory submission. The Biostatistics function is an integral part of every step of clinical development at Scholar Rock, and the Senior Manager/Associate Director, Biostatistics plays a key role at the study level, and potentially at a clinical development program level. Key responsibilities include day-to-day clinical statistician activities, clinical trial design, statistical analysis development, carrying out modeling, simulation and analysis, and leading statistical deliverables.
About Scholar Rock Holding
Scholar Rock Holding is a biopharmaceutical company committed to discovering and developing innovative medicines that target the transforming growth factor beta (TGFβ) superfamily of proteins to treat serious diseases with high unmet medical need.
Job overview
Employment type
Full Time
Experience level
Senior
Work type
Hybrid
Department
Development
Posted
on Sep 22, 2026
Financials
Type
public
Annual Revenue
--
Market Cap
$3.2B+
Membership
Join Refer Me Membership to get referred to this role at Scholar Rock Holding.